• allemand
• anglais
• francais
• italien

The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis.
Umbehr MH, Müntener M, Hany T, Sulser T, Bachmann LM.
Eur Urol. 2013 Jul;64(1):106-17.

18F-FDG-PET/CT for the assessment of the contralateral neck in patients with head and neck squamous cell carcinoma.
Kastrinidis N, Kuhn FP, Hany TF, Ahmad N, Huber GF, Haerle SK.
Laryngoscope. 2013 May;123(5):1210-5.

Physiologic [18F]fluorodeoxyglucose uptake of floor of mouth muscles in PET/CT imaging: a problem of body position during FDG uptake?
Haerle SK, Hany TF, Ahmad N, Burger I, Huber GF, Schmid DT.
Cancer Imaging. 2013 Feb 20;13:1-7.

Correlation between therapy response assessment using FDG PET/CT and histopathologic tumor regression grade in hepatic metastasis of colorectal carcinoma after neoadjuvant therapy. Burger IA, Schwarz EI, Samarin A, Breitenstein S, Weber A, Hany TF.
Ann Nucl Med. 2013 Feb;27(2):177-83.

Combined PET/CT-perfusion in patients with head and neck cancers.
Veit-Haibach P, Schmid D, Strobel K, Soyka JD, Schaefer NG, Haerle SK, Huber G, Studer G, Seifert B, Hany TF.
Eur Radiol. 2013 Jan;23(1):163-73.

Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer.
Soyka JD, Muster MA, Schmid DT, Seifert B, Schick U, Miralbell R, Jorcano S, Zaugg K, Seifert HH, Veit-Haibach P, Strobel K, Schaefer NG, Husarik DB, Hany TF.
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):936-43.

Pain-related F-18 FDG uptake of the corrugator supercilii muscles in PET/CT.
Burger IA, Schmid DT, Hany TF.
Clin Nucl Med. 2012 Jan;37(1):e11-2.

Improved treatment outcomes with (18) F-FDG PET/CT for patients with advanced head and neck squamous cell carcinoma.
Haerle SK, Soyka MB, Schmid DT, Ahmad N, Huber GF, Crook DW, Hany TF.
Head Neck. 2012 Sep;34(9):1205-11.

Incidence and intensity of F-18 FDG uptake after vaccination with H1N1 vaccine.
Burger IA, Husmann L, Hany TF, Schmid DT, Schaefer NG.
Clin Nucl Med. 2011 Oct;36(10):848-53.

Profiling gastrin-releasing peptide receptor in prostate tissues: clinical implications and molecular correlates.
Beer M, Montani M, Gerhardt J, Wild PJ, Hany TF, Hermanns T, Müntener M, Kristiansen G.
Prostate. 2012 Feb;72(3):318-25.

Molecular imaging of malignant tumor metabolism: whole-body image fusion of DWI/CT vs. PET/CT.
Reiner CS, Fischer MA, Hany T, Stolzmann P, Nanz D, Donati OF, Weishaupt D, von Schulthess GK, Scheffel H.
Acad Radiol. 2011 Aug;18(8):940-6.

The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
Haerle SK, Schmid DT, Ahmad N, Hany TF, Stoeckli SJ.
Oral Oncol. 2011 Jul;47(7):653-9.

Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology.
Stoeckli SJ, Haerle SK, Strobel K, Haile SR, Hany TF, Schuknecht B
Head Neck. 2012 Apr;34(4):469-76.

Assessment of successful incorporation of cages after cervical or lumbar intercorporal fusion with [(18)F]fluoride positron-emission tomography/computed tomography.
Fischer DR, Zweifel K, Treyer V, Hesselmann R, Johayem A, Stumpe KD, von Schulthess GK, Hany TF, Strobel K.
Eur Spine J. 2011 Apr;20(4):640-8.

FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position.
Burger IA, Scheiner DA, Crook DW, Treyer V, Hany TF, von Schulthess GK.
Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):90-6

Accuracy of CT parameters for assessment of tumour size and aggressiveness in lung adenocarcinoma with bronchoalveolar elements.
Bhure UN, Lardinois D, Kalff V, Hany TF, Soltermann A, Seifert B, Steinert HC.
Br J Radiol. 2010 Oct;83(994):841-9.

Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT.
Fischer MA, Nanz D, Hany T, Reiner CS, Stolzmann P, Donati OF, Breitenstein S, Schneider P, Weishaupt D, von Schulthess GK, Scheffel H.
Eur Radiol. 2011 Feb;21(2):246-55.

Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component.
Veit-Haibach P, Schiesser M, Soyka J, Strobel K, Schaefer NG, Hesselmann R, Clavien PA, Hany TF.
Eur Radiol. 2011 Feb;21(2):256-64

Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?
Haerle SK, Huber GF, Hany TF, Ahmad N, Schmid DT.
Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1635-40

Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT.
Veit-Haibach P, Treyer V, Strobel K, Soyka JD, Husmann L, Schaefer NG, Tschopp A, Hany TF.
Abdom Imaging. 2010 Oct;35(5):528-36

18F-FDG-PET and MRI in patients with malignancies of the liver and pancreas. Accuracy of retrospective multimodality image registration by using the CT-component of PET/CT.
Donati OF, Reiner CS, Hany TF, Fornaro J, von Schulthess GK, Marincek B, Weishaupt D.
Nuklearmedizin 2010;49(3):106-14

Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, Weishaupt D.
J Nucl Med. 2010 May;51(5):692-9

Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine.
Soyka JD, Strobel K, Veit-Haibach P, Schaefer NG, Schmid DT, Tschopp A, Hany TF.
J Nucl Med. 2010 Apr;51(4):507-10

Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours.
Schiesser M, Veit-Haibach P, Muller MK, Weber M, Bauerfeind P, Hany T, Clavien PA.
Br J Surg. 2010 May;97(5):691-7

Therapeutic impact of [(18)F]fluoride positron-emission tomography/computed tomography on patients with unclear foot pain.
Fischer DR, Maquieira GJ, Espinosa N, Zanetti M, Hesselmann R, Johayem A, Hany TF, von Schulthess GK, Strobel K.
Skeletal Radiol. 2010 Oct;39(10):987-97

Risk-adapted FDG-PET/CT-based follow-up in patients with diffuse large B-cell lymphoma after first-line therapy.
Petrausch U, Samaras P, Haile SR, Veit-Haibach P, Soyka JD, Knuth A, Hany TF, Mischo A, Renner C, Schäefer NG.
Ann Oncol. 2010 Aug;21(8):1694-8

Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study.
Fischer MA, Donati O, Heinrich S, Weber A, Hany TF, Soldini D, Alkadhi H, Marincek B, Scheffel H.
JOP. 2010 Jan 8;11(1):49-54.

Hodgkin’s lymphoma in remission after first-line therapy: which patients need FDG-PET/CT for follow-up?
Petrausch U, Samaras P, Veit-Haibach P, Tschopp A, Soyka JD, Knuth A, Hany TF, Mischo A, Renner C, Schaefer NG.
Ann Oncol. 2010 May;21(5):1053-7

(18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Haerle SK, Strobel K, Hany TF, Sidler D, Stoeckli SJ.
Head Neck. 2010 Mar;32(3):319-25

Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02).
Klaeser B, Nitzsche E, Schuller JC, Köberle D, Widmer L, Balmer-Majno S, Hany T, Cescato-Wenger C, Brauchli P, Zünd M, Pestalozzi BC, Caspar C, Albrecht S, von Moos R, Ruhstaller T.
Onkologie. 2009 Dec;32(12):724-30

Is There an Additional Value of SPECT/CT Over Planar Lymphoscintigraphy for Sentinel Node Mapping in Oral/Oropharyngeal Squamous Cell Carcinoma?
Haerle SK, Hany TF, Strobel K, Sidler D, Stoeckli SJ.
Ann Surg Oncol. 2009 Nov;16(11):3118-24

Head and neck squamous cell carcinoma (HNSCC)–detection of synchronous primaries with 18F-FDG-PET/CT.
Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF.
Eur J Nucl Med Mol Imaging. 2009 Jun;36(6):919-27

Neoadjuvant chemotherapy generates a significant tumor response in resectable pancreatic cancer without increasing morbidity: results of a prospective phase II trial.
Heinrich S, Schäfer M, Weber A, Hany TF, Bhure U, Pestalozzi BC, Clavien PA.
Ann Surg. 2008 Dec;248(6):1014-22

Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography.
Goerres GW, Schuknecht B, Schmid DT, Stoeckli SJ, Hany TF (2008)
Clin Imaging. 2008 Nov-Dec;32(6):431-7

The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT.
Strobel K, Exner UE, Stumpe KD, Hany TF, Bode B, Mende K, Veit-Haibach P, von Schulthess GK, Hodler J.
Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2000-8

Contrast-Enhanced 18F-FDG PET/CT: 1-Stop-Shop Imaging for Assessing the Resectability of Pancreatic Cancer.
Strobel K, Heinrich S, Bhure U, Soyka J, Veit-Haibach P, Pestalozzi BC, Clavien PA, Hany TF.
J Nucl Med. 2008;49(9):1408-13

Imaging and PET-PET/CT imaging.
Schulthess GK, Hany TF.
J Radiol. 2008 89(3 Pt 2):438-47; quiz 448. Review

Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
Soyka JD, Veit-Haibach P, Strobel K, Breitenstein S, Tschopp A, Mende KA, Lago MP, Hany TF.
J Nucl Med. 2008 Mar;49(3):354-61

Pathologies of the lower abdomen and pelvis: PET/CT reduces interpretation errors due to urinary contamination.
Harder JN, Hany TF, von Schulthess GK, Goerres GW.
Clin Imaging. 2008 Jan-Feb;32(1):16-21

Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT.
Wildi SM, Gubler C, Hany T, Petrowsky H, Clavien PA, Jochum W, Gerlach T, Fried M, Mullhaupt B.
J Clin Ultrasound. 2008 Jan;36(1):20-6.

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
Husarik DB, Miralbell R, Dubs M, John H, Giger OT, Gelet A, Cservenyàk T, Hany TF.
Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):253-63

S-100B and FDG-PET/CT in therapy response assessment of melanoma patients.
Strobel K, Skalsky J, Steinert HC, Dummer R, Hany TF, Bhure U, Seifert B, Perez Lago M, Joller-Jemelka H, Kalff V.
Dermatology. 2007 215(3):192-201

Sciatic nerve neurolymphomatosis – extent and therapy response assessment with PET/CT.
Strobel K, Fischer K, Hany TF, Poryazova R, Jung HH.
Clin Nucl Med. 2007 Aug;32(8):646-8

High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases.
Strobel K, Dummer R, Husarik DB, Perez Lago M, Hany TF, Steinert HC.
Radiology. 2007 Aug;244(2):566-74

Diagnostic value of F-18-FDG PET/CT in Hodgkin’s disease after first line therapy: Is a biopsy of FDG avid lesions still needed ?
Schaefer NG, Taverna C., Strobel K, Wastl C, Kurrer M, Hany TF.
Radiology 2007 244(1):257-62

PET/CT staging followed by Intensity-Modulated Radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison.
Rothschild S, Studer G, Seifert B, Huguenin P, Glanzmann C, Davis JB, Lutolf UM, Hany TF, Ciernik IF.
Radiat Oncol. 2007(9);2:22

Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
Strobel K, Rudy M, Treyer V, Veit-Haibach P, Burger C, Hany TF.
Nucl Med Commun. 2007;28(7):555-9

Characterization of focal bone lesions in the axial skeleton – performance of planar bone scintigraphy compared with SPECT and SPECT fused with CT.
Strobel K, Burger C, Seifert B, Husarik DB, Soyka JD, Hany TF.
Am J Roentgenol 2007;188(5):W467-74

18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
Vees H, Buchegger F, Albrecht S, Khan H, Husarik D, Zaidi H, Soloviev D, Hany TF, Miralbell R.
BJU Int. 2007 Jun;99(6):1415-20. Epub 2007 Apr 8.

FDG PET/CT imaging of a gastric fistula.
Strobel K, Zippelius A, Hany TF.
Clin Nucl Med. 2007 32(4):336-7

FDG-negative signet ring cell cancer of the stomach with FDG-positive skin metastases.
Bhure U, Schmitt AM, Pestalozzi BC, Hany TF, Strobel K.
Clin Nucl Med. 2007 32(3):226-8

Small bowel invagination caused by intestinal melanoma metastasis: unsuspected diagnosis by FDG-PET/CT imaging.
Strobel K, Skalsky J, Hany TF, Dummer R, Steinert HC.
Clin Nucl Med 2007;32(3):213-4

Cost-effective Therapy Response Assessment in Lymphoma Patients Using FDG-PET/CT: Is an End-of Treatment Exam Necessary in all Patients?
Strobel K ,Schaefer NG , Renner C, Veit-Haibach P, Husarik D, Koma AY, Hany TF.
Ann Oncol 2007;18(4):658-64

3D-segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate.
Ciernik IF, Brown DW, Schmid D, Hany T, Egli P, Davis JB.
Technol Cancer Res Treat 2007;6(1):23-30

MIBG-SPECT/CT-angiography with 3-D reconstruction of an extra-adrenal phaeochromocytoma with dissection of an aortic aneurysm.
Strobel K, Burger C, Schneider P, Weber M, Hany TF.
Eur J Nucl Med Mol Imaging. 2007 Jan;34(1):150

Bone Involvement in Patients with Lymphoma: The role of FDG-PET/CT.
Schaefer NG, Strobel K, Taverna C, Hany TF.
Eur J Nucl Med Mol Imaging. 2007;34(1):60-7

Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
Strobel K, Schaefer NG, Husarik DB, Hany TF, Steinert H.
Clin Nucl Med; 2006;31(10):624-6

Digital X-ray radiogrammetry better identifies osteoarthritis patients with a low bone mineral density than quantitative ultrasound.
Goerres GW, Frey D, Hany TF, Seifert B, Hauselmann HJ, Studer A, Hauser D, Zilic N, Michel BA, Hans D, Uebelhart D.
Eur Radiol 2007 (4):965-74

How useful is PET/CT imaging in the management of Post-transplant Lymphoproliferative Disorder after liver transplantation?
McCormack L, Hany TI, Hübner M, Petrowsky H, Mullhaupt B, Clavien PA.
Am J Transplant. 2006 Jul;6(7):1731-6

Changing PET/CT manifestation of neurolymphomatosis.
Strobel K, Pestalozzi B, Ciernik I, Schaefer NG, Koma AY, Hany TF.
Eur J Nucl Med Mol Imaging. 2006 33(10):1244

Impact of Integrated Positron Emission Tomography and Computed Tomography on Staging and Management of Gallbladder Cancer and Cholangiocarcinoma.
Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, Clavien PA.
J Hepatol 2006;45(1):43-50.

PET/CT of a Brodie Abscess.
Strobel K, Hany TF, Exner GU.
Clin Nucl Med. 2006;31(4):210.

Integrated PET/CT: current applications and future directions.
von Schulthess GK, Steinert HC, Hany TF.
Radiology. 2006 Feb;238(2):405-22. Review

How much intravenous contrast is needed in FDG-PET/CT?
Strobel K, Thuerl CM, Hany TF.
Nuklearmedizin 2005;44 Suppl 1:S32-7

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness.
Heinrich S, Goerres GW, Schafer M, Sagmeister M, Bauerfeind P, Pestalozzi BC, Hany TF, von Schulthess GK, Clavien PA.
Ann Surg 2005 Aug;242(2):235-43

Integrated PET/CT for the Assessment of Coronary Artery Disease: A Feasibility Study.
Namdar M, Hany TF, Koepfli P, Siegrist PT, Burger C, Wyss CA, Luscher TF, Schulthess GK Kaufmann PA.
J Nucl Med 2005;46(6):930-5

Fluorocholine PET/CT in patients with prostate cancer: initial experience.
Schmid DT, John H, Zweifel R, Cservenyak T, Westera G, Goerres GW, von Schulthess GK, Hany TF.
Radiology. 2005 May;235(2):623-8. DOI

The value of PET, CT and in-line PET/CT in patients with gastrointestinal stromal tumors (GIST): long-term outcome of patients treated with trea imatinib mesylate.
Goerres GW, Stupp R, Barghouth G, Hany TF ; Pestalozzi B, Dizendorf E, Schnyder P, Luthi F, von Schulthess GK, Leyvraz S.
Eur J Nucl Med Mol Imaging 2005;32(2):153-62

Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer to the liver?
Selzner M, Hany TF*, Wildbrett P, McCormack L, Kadry Z, Clavien PA.
Ann Surg 2004 Dec;240(6):1027-34; discussion 1035-6

PET/CT: Combining function and morphology.
Hany TF, von Schulthess GK.
In: Molecular Imaging. Anessential tool in preclinical research, diagnostic imaging and therapy. Ernst Schering research foundation Workshop 49. Rev.  Ed. Bogdanov AA Jr., Licha K. Springer 2005(49):85-98.

Time-Resolved 3D MR Angiography of the Abdomen with a Real-Time System
Wieben O, Grist TM, Hany TF, Thornton FJ, Glaser JK, Skuldt DH, Block WF.
Magn Reson Med 2004 Oct;52(4): 921-6

Coregistered 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (PET/CT) in Patients with Aggressive Non-Hodgkin Lymphoma and Hodgkin’s Disease: Do We Need Contrast-Enhanced CT ?
Schaefer NG, Hany TF*, Taverna C, Stumpe KDM, von Schulthess GK, Goerres GW.
Radiology 2004 Sep;232(3):823-9

CT-Attenuation Correction in Quantitative Myocardial Perfusion PET Imaging Using a Combined PET/CT Scanner.
Koepfli P, Hany TF, Wyss CA, Namdar M, Burger C, Kostantinidis A, Berthold T, von Schulthess GK, Kaufmann PA .
J Nucl Med. 2004 Apr;45(4):537-42

FDG-PET in the differentiation of infection and aseptic loosening in patients with total hip replacements: Comparison with conventional radiographs and three-phase bone scintigraphy.
Stumpe KDM, Nötzli H, Zanetti M, Kamel E, Hany TF, Görres GW, von Schulthess GK, Hodler J.
Radiology 2004 May;231(2):333-41

Iatrogenic FDG foci in the lungs: a pitfall of PET image interpretation.
Hany TF, Heuberger J, von Schulthess GK.
Eur Radiol. 2003 Sep;13(9):2122-7

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC.
New Engl J Med. 2003 19;348(25):2500-7

Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies.
Dizendorf E, Hany TF, Buck A, von Schulthess GK, Burger C.
J Nucl Med. 2003 May;44(5):732-8

Accuracy of Image Co-Registration of Pulmonary Lesions in Patients with Non-Small Cell Lung Cancer using an Integrated PET/CT System.
Goerres GW, Kamel E, Seifert B, Burger C, Buck A, Hany TF, von Schulthess GK.
J Nucl Med 2002 43(11):1469-75

Improvement of diagnostic Accuracy of PET imaging using an in-line PET-CT sysem: initial results.
Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK.
Radiology 2002;225(2):575-81

PET and PET/CT of the Head and Neck: FDG Uptake in Normal Anatomy, Benign Lesions and Treatment Effects.
Goerres GW, von Schulthess GK, Hany TF.
AJR Am J Roentgenol 2002;179(5):1337-43

Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region.
Hany TF, Gharehpapagh E, Kamel E, Buck A, Himms-Hagen J, von Schulthess GK.
Eur J Nucl Med Mol Imaging 2002;29(10):1393-8

Absolute Quantification of Cerebral Blood Flow with MR, Reproducibility of the Method and Comparison with H215O PET.
Carroll TJ, Teneggi V, Jobin M, Squassante L, Treyer V, Hany TF, Burger C, Wang L, Bye A, von Schulthess GK, Buck A.
J Cerebr Blood F Met 2002;22(9):1149-56

Application of Oral Contrast Media in Co-Registered PET-CT Imaging.
Dizendorf EV, Treyer V, von Schulthess GK, Hany TF.
AJR Am J Roentgenol 2002;179:477-481

Fusion PET-CT imaging of Neurolymphomatosis.
Trojan A, Jermann M, Taverna C, Hany TF.
Ann Oncol 2002;13(5):802-5

Head and neck imaging with PET and PET/CT: artifacts from dental metallic implants.
Goerres GW, Hany TF, Kamel E, von Schulthess GK, Buck A.
Eur J Nucl Med Mol Imaging 29: 367-370

Evaluation of CT attenuation maps acquired with different tube currents and comparison to 68Ge attenuation correction in a combined PET/CT system.
Kamel E, Hany TF, Burger C, Treyer V, Lonn AHR, von Schulthess GK, Buck A.
Eur J Nucl Med Mol Imaging 2002;29: 346-350

Combined Time-Resolved and High-Spatial Resolution 3D MRA Using an Extended Adaptive Acquisition.
Mazaheri Y, Carroll TJ, Du J, Block WF, Fain SB, Hany TF, Aagaard BL, Strother CM, Mistretta CA, Grist TM.
J Magn Reson Imaging 2002;15:291-301

The effect of injection rate on time-resolved contrast-enhanced peripheral MRA.
Carroll TJ, Korosec FR, Swan JS, Hany TF, Grist TM, Mistretta CA.
J Magn Reson Imaging. 2001 Oct;14(4):401-10

Aorta and runoff vessels: single-injection MR angiography with automated table movement compared with multiinjection time-resolved MR angiography–initial results.
Hany TF, Carroll TJ, Omary RA, Esparza-Coss E, Korosec FR, Mistretta CA, Grist TM.
Radiology 2001;221: 266-72

Pelvic and lower extremity arterial imaging:diagnostic performance of 3D contrast-enhanced MRA.
Ruehm SG, Hany TF, Pfammatter T, Schneider E, Ladd M, Debatin JF.
AJR Am J Roentgenol 2001;174:1127-1135

Images in cardiovascular medicine. Cerebral arterial embolism from a protruding atheroma of the aortic arch after a nonpenetrating chest trauma.
Corti R, Alerci M, Tosi C, Tutta P, Hany T, and Gallino A.
Circulation 1999;100:1009-10

Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease.
Leung DA, Hoffmann U, Pfammatter T, Hany TF, Rainoni L, Hilfiker P, Schneider E, Zimmermann-Paul GG, and Debatin JF.
Hypertension 1999;33:726-31

3D MR gastrography: exoscopic and endoscopic analysis of the stomach.
Schmid MR, Hany TF, Knesplova L, Schlumpf R, and Debatin JF.
Eur Radiol 1999;9:73-7

Virtual MR cholangiography.
Dubno B, Debatin JF, Luboldt W, Schmidt M, Hany TF, and Bauerfeind P.
AJR Am J Roentgenol 1998;171:1547-50

Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries.
Hany TF, Schmidt M, Hilfiker PR, Steiner P, Bachmann U, Debatin JF.
Magn Reson Imaging 1998;16:901-6

Contrast-enhanced three-dimensional magnetic resonance angiography of the splanchnic vasculature before and after caloric stimulation.
Hany TF, Schmidt M, Schoenenberger AW, and Debatin JF.
Original investigation. Invest Radiol 1998 (33):682-6

Contrast-enhanced magnetic resonance angiography of the renal arteries.
Hany TF, Leung DA, Pfammatter T, and Debatin JF.
Original investigation. Invest Radiol 1998;33:653-9

Value of image subtraction in 3D gadolinium-enhanced MR angiography of the renal arteries.
Leung DA, Pelkonen P, Hany TF, Zimmermann G, Pfammatter T, and Debatin JF
J Magn Reson Imaging 1998 (8):598-602

MR-based assessment of vascular morphology and function.
Debatin JF, and Hany TF.
Eur Radiol 1998;8:528-39

[Clinical use of contrast-enhanced MR angiography].
Hany TF, Pfammatter T, and Debatin JF (1998)
SWISS MED WKLY Schweiz Med Wochenschr 128:544-51 (IPF: 1.681)

Diagnostic impact of four postprocessing techniques in evaluating contrast-enhanced three-dimensional MR angiography.
Hany TF, Schmidt M, Davis CP, Gohde SC, and Debatin JF.
Am J Roentgenol 1998;170:907-12

Three-dimensional contrast-enhanced magnetic resonance angiography of the abdominal arterial system.
Leung DA, Hany TF, and Debatin JF.
Cardiovasc Inter Rad 1998;21:1-10

Dynamic MR defecography with a superconducting, open-configuration MR system.
Schoenenberger AW, Debatin JF, Guldenschuh I, Hany TF, Steiner P, and Krestin GP.
Radiology 1998;206:641-6

Postprocessing techniques for gadolinium-enhanced three-dimensional MR angiography.
Davis CP, Hany TF, Wildermuth S, Schmidt M, and Debatin JF.
Radiographics 1997;17:1061-77

Evaluation of the aortoiliac and renal arteries: comparison of breath- hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography.
Hany TF, Debatin JF, Leung DA, and Pfammatter T.
Radiology 1997;204:357-62

Wertigkeit der kontrastverstärkten 3D MR-Angiographie der Nierenarterien.
Hany TF, Pfammatter T, Schmidt M, Leung DA, and Debatin JF.
Radiologe 1997;37:547-53

Ultraschnelle, kontrastverstärkte 3 D MR Angiographie der Aorta und Nierenarterien in Apnoe.
Hany TF, Pfammatter T, Schmidt M, Leung DA, and Debatin JF.
ROFO-FORTSCHR RONTG 1997;166:397- 405

Optimization of contrast timing for breath-hold three-dimensional MR angiography.
Hany TF, McKinnon GC, Leung DA, Pfammatter T, and Debatin JF.
J Magn Reson Imaging 1997;7:551-6

MR appearance of isolated noncompaction of the left ventricle.
Hany TF, Jenni R, and Debatin JF.
J Magn Reson Imaging 1997;7:437-8

Contrast-enhanced, ultrafast 3D pulmonary MR angiography in a single breath-hold: initial assessment of imaging performance.
Steiner P, McKinnon GC, Romanowski B, Goehde SC, Hany T, and Debatin JF.
J Magn Reson Imaging 1997;7:177-82